lomefloxacin has been researched along with Community Acquired Infection in 1 studies
lomefloxacin: structure given in first source
lomefloxacin : A fluoroquinolone antibiotic, used (generally as the hydrochloride salt) to treat bacterial infections including bronchitis and urinary tract infections. It is also used to prevent urinary tract infections prior to surgery.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ellis-Pegler, RB | 1 |
| Hyman, LK | 1 |
| Ingram, RJ | 1 |
| McCarthy, M | 1 |
1 trial available for lomefloxacin and Community Acquired Infection
| Article | Year |
|---|---|
A placebo controlled evaluation of lomefloxacin in the treatment of bacterial diarrhoea in the community.
Topics: Adult; Anti-Infective Agents; Campylobacter; Campylobacter Infections; Community-Acquired Infections | 1995 |